US Stock MarketDetailed Quotes

ANRO Alto Neuroscience

Watchlist
  • 4.310
  • +0.220+5.38%
Close Nov 22 16:00 ET
  • 4.450
  • +0.140+3.24%
Post 20:01 ET
116.24MMarket Cap-2023P/E (TTM)

Alto Neuroscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-51.01%-11.73M
-76.25%-11.69M
-45.97%-10.98M
-64.01%-33.45M
-91.40%-11.52M
-7.77M
-6.64M
-7.52M
-120.19%-20.39M
-6.02M
Net income from continuing operations
-83.60%-16.78M
-85.04%-16.03M
-84.20%-13.42M
-31.02%-36.31M
-46.59%-11.22M
---9.14M
---8.66M
---7.28M
-201.62%-27.71M
---7.65M
Operating gains losses
101.77%4K
117.65%18K
2,309.09%243K
-204.34%-385K
82.64%-46K
---226K
---102K
---11K
244.86%369K
---265K
Depreciation and amortization
93.65%122K
0.89%113K
12.79%97K
9.06%373K
15.46%112K
--63K
--112K
--86K
135.86%342K
--97K
Other non cash items
-10.37%147K
461.39%887K
-3.95%170K
157.03%676K
342.50%177K
--164K
--158K
--177K
1,361.11%263K
--40K
Change In working capital
234.05%2.79M
138.33%1.43M
73.87%-255K
-115.24%-698K
-241.32%-1.16M
--834K
--600K
---976K
900.52%4.58M
--818K
-Change in receivables
--0
--0
121.62%8K
-71.93%325K
--0
--295K
--67K
---37K
190.12%1.16M
--1.02M
-Change in prepaid assets
1,007.32%744K
-67.96%124K
-285.56%-1.79M
42.37%-34K
144.17%125K
---82K
--387K
---464K
84.64%-59K
---283K
-Change in payables and accrued expense
228.82%2.04M
794.52%1.31M
421.26%1.53M
-128.42%-989K
-1,742.31%-1.28M
--621K
--146K
---475K
217.23%3.48M
--78K
Cash from discontinued investing activities
Operating cash flow
-51.01%-11.73M
-76.25%-11.69M
-45.97%-10.98M
-64.01%-33.45M
-91.40%-11.52M
---7.77M
---6.64M
---7.52M
-120.19%-20.39M
---6.02M
Investing cash flow
Cash flow from continuing investing activities
-2,237.21%-1.01M
-529.63%-340K
-966.67%-224K
35.79%-470K
-467.74%-352K
-43K
-54K
-21K
-7.65%-732K
-62K
Capital expenditure reported
-2,237.21%-1.01M
-529.63%-340K
-966.67%-224K
35.79%-470K
-467.74%-352K
---43K
---54K
---21K
-7.65%-732K
---62K
Cash from discontinued investing activities
Investing cash flow
-2,237.21%-1.01M
-529.63%-340K
-966.67%-224K
35.79%-470K
-467.74%-352K
---43K
---54K
---21K
-7.65%-732K
---62K
Financing cash flow
Cash flow from continuing financing activities
2,587.76%1.32M
-358.82%-234K
438.24%134.56M
55.59%68.13M
118.81%43.13M
49K
-51K
25M
38.19%43.79M
19.71M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--9.83M
----
Net common stock issuance
--0
--0
--137.58M
320.93%181K
4,425.00%181K
--0
--0
--0
514.29%43K
--4K
Net preferred stock issuance
--0
--0
--0
104.31%70M
349.74%45.15M
---60K
---94K
--25M
7.45%34.26M
--10.04M
Proceeds from stock option exercised by employees
-38.53%67K
41.86%61K
--10K
----
----
--109K
--43K
--0
----
----
Net other financing activities
--1.25M
---295K
---3.03M
-501.47%-2.05M
----
----
----
----
-66.34%-341K
---157K
Cash from discontinued financing activities
Financing cash flow
2,587.76%1.32M
-358.82%-234K
438.24%134.56M
55.59%68.13M
118.81%43.13M
--49K
---51K
--25M
38.19%43.79M
--19.71M
Net cash flow
Beginning cash position
228.01%193.62M
213.01%205.9M
70.75%82.55M
88.07%48.34M
47.83%51.29M
--59.03M
--65.78M
--48.34M
541.18%25.71M
--34.7M
Current changes in cash
-47.11%-11.41M
-82.02%-12.27M
606.69%123.35M
50.96%34.21M
129.33%31.26M
---7.76M
---6.74M
--17.46M
4.22%22.66M
--13.63M
Effect of exchange rate changes
-138.89%-7K
54.55%-5K
73.68%-5K
66.67%-8K
-80.00%4K
--18K
---11K
---19K
52.00%-24K
--20K
End cash Position
255.25%182.2M
228.01%193.62M
213.01%205.9M
70.75%82.55M
70.75%82.55M
--51.29M
--59.03M
--65.78M
88.07%48.34M
--48.34M
Free cash flow
-63.05%-12.73M
-79.91%-12.03M
-48.54%-11.21M
-60.55%-33.92M
-95.23%-11.88M
---7.81M
---6.69M
---7.55M
-112.49%-21.13M
---6.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -51.01%-11.73M-76.25%-11.69M-45.97%-10.98M-64.01%-33.45M-91.40%-11.52M-7.77M-6.64M-7.52M-120.19%-20.39M-6.02M
Net income from continuing operations -83.60%-16.78M-85.04%-16.03M-84.20%-13.42M-31.02%-36.31M-46.59%-11.22M---9.14M---8.66M---7.28M-201.62%-27.71M---7.65M
Operating gains losses 101.77%4K117.65%18K2,309.09%243K-204.34%-385K82.64%-46K---226K---102K---11K244.86%369K---265K
Depreciation and amortization 93.65%122K0.89%113K12.79%97K9.06%373K15.46%112K--63K--112K--86K135.86%342K--97K
Other non cash items -10.37%147K461.39%887K-3.95%170K157.03%676K342.50%177K--164K--158K--177K1,361.11%263K--40K
Change In working capital 234.05%2.79M138.33%1.43M73.87%-255K-115.24%-698K-241.32%-1.16M--834K--600K---976K900.52%4.58M--818K
-Change in receivables --0--0121.62%8K-71.93%325K--0--295K--67K---37K190.12%1.16M--1.02M
-Change in prepaid assets 1,007.32%744K-67.96%124K-285.56%-1.79M42.37%-34K144.17%125K---82K--387K---464K84.64%-59K---283K
-Change in payables and accrued expense 228.82%2.04M794.52%1.31M421.26%1.53M-128.42%-989K-1,742.31%-1.28M--621K--146K---475K217.23%3.48M--78K
Cash from discontinued investing activities
Operating cash flow -51.01%-11.73M-76.25%-11.69M-45.97%-10.98M-64.01%-33.45M-91.40%-11.52M---7.77M---6.64M---7.52M-120.19%-20.39M---6.02M
Investing cash flow
Cash flow from continuing investing activities -2,237.21%-1.01M-529.63%-340K-966.67%-224K35.79%-470K-467.74%-352K-43K-54K-21K-7.65%-732K-62K
Capital expenditure reported -2,237.21%-1.01M-529.63%-340K-966.67%-224K35.79%-470K-467.74%-352K---43K---54K---21K-7.65%-732K---62K
Cash from discontinued investing activities
Investing cash flow -2,237.21%-1.01M-529.63%-340K-966.67%-224K35.79%-470K-467.74%-352K---43K---54K---21K-7.65%-732K---62K
Financing cash flow
Cash flow from continuing financing activities 2,587.76%1.32M-358.82%-234K438.24%134.56M55.59%68.13M118.81%43.13M49K-51K25M38.19%43.79M19.71M
Net issuance payments of debt --------------0------------------9.83M----
Net common stock issuance --0--0--137.58M320.93%181K4,425.00%181K--0--0--0514.29%43K--4K
Net preferred stock issuance --0--0--0104.31%70M349.74%45.15M---60K---94K--25M7.45%34.26M--10.04M
Proceeds from stock option exercised by employees -38.53%67K41.86%61K--10K----------109K--43K--0--------
Net other financing activities --1.25M---295K---3.03M-501.47%-2.05M-----------------66.34%-341K---157K
Cash from discontinued financing activities
Financing cash flow 2,587.76%1.32M-358.82%-234K438.24%134.56M55.59%68.13M118.81%43.13M--49K---51K--25M38.19%43.79M--19.71M
Net cash flow
Beginning cash position 228.01%193.62M213.01%205.9M70.75%82.55M88.07%48.34M47.83%51.29M--59.03M--65.78M--48.34M541.18%25.71M--34.7M
Current changes in cash -47.11%-11.41M-82.02%-12.27M606.69%123.35M50.96%34.21M129.33%31.26M---7.76M---6.74M--17.46M4.22%22.66M--13.63M
Effect of exchange rate changes -138.89%-7K54.55%-5K73.68%-5K66.67%-8K-80.00%4K--18K---11K---19K52.00%-24K--20K
End cash Position 255.25%182.2M228.01%193.62M213.01%205.9M70.75%82.55M70.75%82.55M--51.29M--59.03M--65.78M88.07%48.34M--48.34M
Free cash flow -63.05%-12.73M-79.91%-12.03M-48.54%-11.21M-60.55%-33.92M-95.23%-11.88M---7.81M---6.69M---7.55M-112.49%-21.13M---6.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data